Yuting Sang

2.2k citations
20 papers · 1.5k · 1 hit paper · h-index 12

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Circular RNAs in diseases
    • RNA modifications and cancer
    • Extracellular vesicles in disease
    • RNA Research and Splicing

Papers in

    • MicroRNA in disease regulation 8
    • Breast Cancer Treatment Studies 5
    • Cancer-related molecular mechanisms research 5
    • Circular RNAs in diseases 11
    • RNA modifications and cancer 4
    • Extracellular vesicles in disease 2

Yuting Sang

20 papers receiving 1.4k citations

Hit Papers

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer 2019 · 340 citations
3400+2+4Years since publication100200300

Peers

Yuting Sang
Comparison fields: 5 of 87
  • Cancer Research 1.2k
  • Molecular Biology 1.2k
  • Geriatrics and Gerontology 31
  • Oncology 133
  • Immunology 77
Replace Wenjun Cheng with:
Wenjun Cheng China
Xuenong Li China
Yan Zeng China
Fuyin Zhang China
Weijie Liao China
Hiroki Takeshita Japan
Liwei Qiu China
Qianqian Ju China
Alexandra Stavropoulou United Kingdom
Zixuan Zhou China
Yuting Sang relative to Wenjun Cheng China Wenjun Cheng's profile →
Citations per field
00.5×6.2×
Wenjun Cheng · 1×
Citations per year

Countries citing papers authored by Yuting Sang

Since Specialization
Citations

This map shows the geographic impact of Yuting Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Sang more than expected).

Fields of papers citing papers by Yuting Sang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Sang. The network helps show where Yuting Sang may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuting Sang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuting Sang Line = papers co-authored together Yuting Sang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
Hit paper breakdown →
2019340
2 2018233
3 2021178
4 2018145
5 2019113
6 2019107
7 201965
8 202162
9 201859
10 201856
11 202048
12 202131
13 20226
14 20195
15 20235
16 20224
17 20232
18 20212
19 20222
20 20231

About Yuting Sang

Yuting Sang is a scholar working on Cancer Research, Molecular Biology, Oncology, Pathology and Forensic Medicine and Epidemiology, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Circular RNAs in diseases (11 papers), MicroRNA in disease regulation (8 papers), Breast Cancer Treatment Studies (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers), Breast Lesions and Carcinomas (3 papers), Extracellular vesicles in disease (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.2k citations), Geriatrics and Gerontology (31 citations), Oncology (133 citations) and Immunology (77 citations). Yuting Sang has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Qifeng Yang, Yiran Liang, Yaming Li, Ying Liu, Hanwen Zhang, Ning Zhang, Xiaojin Song, Wenjing Zhao, Bing Chen and Lijuan Wang. Their work appears in journals such as Cell Death and Disease, Molecular Therapy — Nucleic Acids, Oncogene, Cancer Research and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact